首页> 美国卫生研究院文献>other >Prevalence and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

【2h】

Prevalence and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

机译：未经治疗的HIV感染中骨矿物质密度低的患病率和危险因素：抗逆转录病毒治疗试验的INSIGHT战略时机的子研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundHIV infection is associated with a higher prevalence of low bone mineral density (BMD) and fractures than the general population. There are limited data in HIV-positive adults, naïve to antiretroviral therapy (ART), to estimate the relative contribution of untreated HIV to bone loss.

机译：背景与普通人群相比，HIV感染与低骨矿物质密度（BMD）和骨折的患病率更高有关。对于未接受抗逆转录病毒治疗（ART）的HIV阳性成年人，只有有限的数据来估计未经治疗的HIV对骨质流失的相对贡献。

著录项

期刊名称 other
作者
Andrew Carr; Birgit Grund; Jacqueline Neuhaus; Ann Schwartz; Jose I Bernardino; David White; Sharlaa Badel-Faesen; Anchalee Avihingsanon; Kristine Ensrud; Jennifer Hoy;
展开▼
作者单位

展开▼
年(卷),期 -1(16),0 1
年度 -1
页码 137–146
总页数 16
原文格式 PDF
正文语种
中图分类
关键词
HIV antiretroviral therapy ART-naïve bone mineral density;

机译：HIV;抗逆转录病毒疗法;未进行过抗病毒治疗;骨矿物质密度;

相似文献

外文文献
中文文献
专利

1. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial [J] . Carr A., Grund B., Neuhaus J., HIV medicine . 2015,第Suppla1期

机译：未经治疗的HIV感染中骨矿物质密度低的患病率和危险因素：抗逆转录病毒疗法（START）试验的INSIGHT战略时机的子研究
2. Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial [J] . Law M. G., Achhra A., Deeks S. G., HIV medicine . 2015,第Suppla1期

机译：在INSIGHT抗逆转录病毒治疗的战略时机（START）试验中，与早期未治疗的HIV感染中低病毒载量相关的临床和人口统计学因素
3. Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial [J] . Matthews G. V., Neuhaus J., Bhagani S., HIV medicine . 2015,第Suppla1期

机译：HIV阳性个体的基线患病率和肝纤维化的预测因素：抗逆转录病毒治疗（START）试验的INSIGHT战略时机的子研究
4. Risk Factor Analysis of Bone Mineral Density Based on Feature Selection in Type 2 Diabetes [C] . Wei Wang, Bingbing Jiang, Shandong Ye, IEEE International Conference on Big Knowledge . 2018

机译：基于特征选择的2型糖尿病骨密度危险因素分析
5. Clinical and genetic risk factors for accelerated bone mineral density loss following blood and/or marrow transplantation [D] . Yao, Song 2009

机译：血液和/或骨髓移植后加速骨矿物质密度损失的临床和遗传危险因素
6. Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial [O] . Matthew G Law, Amit Achhra, Steven G Deeks, -1

机译：在INSIGHT战略性抗逆转录病毒治疗试验中早期未经治疗的HIV感染与低病毒载量相关的临床和人口统计学因素
7. Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial [O] . Law, M, Achhra, A, Deeks, S, 2015

机译：在INSIGHT抗逆转录病毒治疗的战略时机（START）试验中，与早期未治疗的HIV感染中低病毒载量相关的临床和人口统计学因素

Prevalence and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

摘要

著录项

相似文献

相关主题

期刊订阅